AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC grew its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 15.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,701,808 shares of the company’s stock after purchasing an additional 496,453 shares during the period. Segall Bryant & Hamill LLC’s holdings in AdaptHealth were worth $41,571,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the company. Cornercap Investment Counsel Inc. lifted its stake in AdaptHealth by 2.8% during the second quarter. Cornercap Investment Counsel Inc. now owns 46,706 shares of the company’s stock worth $467,000 after purchasing an additional 1,254 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of AdaptHealth by 7.6% in the first quarter. ProShare Advisors LLC now owns 18,994 shares of the company’s stock valued at $219,000 after acquiring an additional 1,338 shares in the last quarter. SummerHaven Investment Management LLC raised its stake in shares of AdaptHealth by 2.7% in the second quarter. SummerHaven Investment Management LLC now owns 57,645 shares of the company’s stock valued at $576,000 after acquiring an additional 1,503 shares in the last quarter. Public Sector Pension Investment Board raised its stake in shares of AdaptHealth by 1.2% in the second quarter. Public Sector Pension Investment Board now owns 171,877 shares of the company’s stock valued at $1,719,000 after acquiring an additional 2,060 shares in the last quarter. Finally, Covestor Ltd raised its stake in shares of AdaptHealth by 279.6% in the first quarter. Covestor Ltd now owns 3,109 shares of the company’s stock valued at $36,000 after acquiring an additional 2,290 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $9.74 on Wednesday. The firm has a market capitalization of $1.31 billion, a PE ratio of -5.90, a price-to-earnings-growth ratio of 1.34 and a beta of 1.11. The business’s fifty day moving average price is $10.56 and its 200 day moving average price is $10.45. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a 12 month low of $6.43 and a 12 month high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). The business had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The business’s quarterly revenue was up .2% compared to the same quarter last year. During the same period last year, the company earned $0.19 EPS. On average, sell-side analysts anticipate that AdaptHealth Corp. will post 0.89 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $11.26, for a total transaction of $45,040.00. Following the transaction, the director now owns 36,899 shares of the company’s stock, valued at approximately $415,482.74. This trade represents a 9.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Shaw Rietkerk sold 25,000 shares of the firm’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. This represents a 10.52 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.43% of the company’s stock.

Analysts Set New Price Targets

AHCO has been the topic of several analyst reports. Robert W. Baird reduced their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. UBS Group reduced their price objective on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Truist Financial reduced their price objective on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, November 15th. Royal Bank of Canada reduced their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday. Finally, Canaccord Genuity Group reduced their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.67.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.